Faculty

Return to the Faculty List

Charles Conway, MD

Current Position
Associate Professor of Psychiatry

University Roles
Director, Treatment Resistant Depression and Neurostimulation Clinic
Interventional Psychiatry Rotation DIrector

Education and Training
B.A., Biology; B.A., Psychology
St. Louis University, 1987

Medical Degree: University of Missouri, Columbia, 1995

Residency: General Psychiatry, Duke University Medical Center, 1999

Major Awards
>>Resident Mentor Award 2011 (chosen by residents), Washington University Department of Psychiatry
>>Best Doctors in America, (Best Doctors, Inc.) 2006,2007,2008,2009,2010,2011,2012
>>NARSAD Young Investigator Award 2007
>>St. Louis University Psych Dept. Resident Faculty Teaching Award (selected by residents) 2004,2007
>>Exemplary Psychiatrist Award, National Alliance for the Mentally Ill (NAMI) 2004
>>Selected for National Institute of Mental Health (NIMH) Summer Research Fellowship (2004)
>>St. Luke Award, Saint Louis University Hospital; (selected as a physician who 'best lived out the Christian mission of St. Louis University Hospital') 2001
>>Chief Resident, John Umstead Hospital, Duke University Psychiatry Residency 1998-1999
>>Phi Beta Kappa 1986

Areas of Clinical Interest
mood disorders,treatment-resistant mood disorders, bipolar disorders


Areas of Research Interests
treatment resistant depression,
bipolar disorders,
neuroimaging of mood disorders


Key Publications
Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI. Association of cerebral metabolic activity changes with vagus nerve stimulation efficacy in treatment-resistant depression. Brain Stimulation, Dec 2012, in press.

Conway CR, Chibnall JT, Gangwani S, Mintun MA, Price JL, Hershey T, Giuffra LA, Bucholz RD, Christensen JJ, Sheline YI. Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: A potential marker for response? J Aff Disorders 2012; 139(3):283-290 PMID: 22397889.

Aaronson ST, Carpenter L, Conway C, Lisanby S, Schwartz T, Moreno F, Dunner D, Lesem M, Thompson P, Husain M, Vine C, Banov M, Bernstein L, Lehman R, Brannon G, Keepers G, O’Reardon J, Rudolph R, Bunker M. Vagus Nerve Stimulation Therapy at Different Amounts of Electrical Charge for Treatment Resistant Depression. Brain Stimulation. Oct 2012, Epub ahead of print. PMID: 23122916

Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA. Cerebral Blood Flow Changes during Acute Vagus Nerve Stimulation for Depression. Psychiatry Res: Neuroimaging 2006 146(2):179-184.

Rush AJ, Sackeim HA, Marnagell LB, George MS, Brannan SK, Davis SM,Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno, F, Schwartz T, Conway C, Burke M, Barry J. Effects of 12 months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study, Biological Psychiatry 2005;58:354-363.

Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Mintun MA. Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder. Brain Stimulation 2012;5(2):163-171 PMID: 22037127.


Funded Research Projects
NIMH(PI):Vagus Nerve Stimulation for Depression: PET Studies

NARSAD Young Investigator Award: Vagus Nerve Stimulation for Depression: PET Studies

Dopaminergic Effects of Adjunctive Aripiprazole in Treatment-Resistant Depression: A Raclopride/F-DOPA Positron Emission Tomography and Functional MRI Study
(Investigator-initiated, industry-sponsored grant funded by Bristol-Myers Squibb)